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Health literate organizations: Are clinical trial sites equipped to recruit minority
and limited health literacy patients?
Abstract
Background. Racial/ethnic minority patients are less likely than non-Latino white patients to participate in
cancer clinical trials. A key barrier to participation is limited health literacy which is more common among
minorities. At the organizational level, it is important that clinical trials sites become better equipped to
recruit minority patients by expanding their organizational health literacy including language competency
and outreach efforts. We explored the characteristics of clinical trial sites that are associated with these
health literate behaviors.
Methods. We identified 353 breast clinical trials recruiting participants in 2006 from four states
(California, Florida, Illinois, and New York) through the National Cancer Institute Physician Data Query
system. From October 2008 to November 2009, we contacted one research team member (RTM) from
each site for a telephone survey to assess the site’s health literate characteristics.
Results. Of 233 RTMs who responded, 93% were female and 89% were US-born. Overall, 48% of sites
offered supplementary trial information, 80% offered materials to assist with patient navigation and 45%
reported outreach efforts. Lower percentages offered information in other languages while 65% offered
professional interpretation services. Sites with >10% limited English proficiency (LEP) patients were more
likely than their counterparts to offer consent forms (OR=3.13, 1.36-7.19) and supplementary information
about trials in other languages (OR=2.52, 1.15-5.52). Sites with diverse patient populations (>10% Latino)
were also more likely than less diverse sites to engage in outreach (OR=1.97, 1.07-3.60), to offer consent
forms (OR=2.72, 1.38-5.36), supplementary information about trials (OR=2.58, 1.24-5.36), and materials to
improve patient navigation (OR=2.50, 1.22-5.13) in other languages.
Conclusions. Efforts to recruit diverse participants were limited. Practice type and diversity of patient
population were associated with sites’ efforts to accommodate these characteristics, suggesting that
sites were responsive to the needs of their patients when diversity was prevalent.
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ABSTRACT
Background Racial/ethnic minority patients are less likely than non-Latino white patients
to participate in cancer clinical trials. A key barrier to participation is limited health
literacy which is more common among minorities. At the organizational level, it is
important that clinical trials sites become better equipped to recruit minority patients by
expanding their organizational health literacy including language competency and
outreach efforts. We explored the characteristics of clinical trial sites that are associated
with these health literate behaviors.
Methods We identified 353 breast clinical trials recruiting participants in 2006 from four
states (California, Florida, Illinois, and New York) through the National Cancer Institute
Physician Data Query system. From October 2008 to November 2009, we contacted one
research team member (RTM) from each site for a telephone survey to assess the site’s
health literate characteristics.
Results Of 233 RTMs who responded, 93% were female and 89% were US-born.
Overall, 48% of sites offered supplementary trial information, 80% offered materials to
assist with patient navigation and 45% reported outreach efforts. Lower percentages
offered information in other languages while 65% offered professional interpretation
services. Sites with >10% limited English proficiency (LEP) patients were more likely
than their counterparts to offer consent forms (OR=3.13, 1.36-7.19) and supplementary
information about trials in other languages (OR=2.52, 1.15-5.52). Sites with diverse
patient populations (>10% Latino) were also more likely than less diverse sites to engage
in outreach (OR=1.97, 1.07-3.60), to offer consent forms (OR=2.72, 1.38-5.36),
supplementary information about trials (OR=2.58, 1.24-5.36), and materials to improve
patient navigation (OR=2.50, 1.22-5.13) in other languages.
Conclusions Efforts to recruit diverse participants were limited. Practice type and
diversity of patient population were associated with sites’ efforts to accommodate these
characteristics, suggesting that sites were responsive to the needs of their patients when
diversity was prevalent.
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INTRODUCTION
Clinical trials provide the foundation for advances in cancer diagnostics and therapeutics
and are the major channel for translating treatment-related discoveries in breast cancer care into
clinical practice (Ford et al., 1990). Clinical trials provide a high standard of medical care and
help to generate new information that helps future patients (American Society of Clinical
Oncology, 2012). To ensure that the benefits and burdens of this research are distributed fairly
among all breast cancer patients, it is important that minorities participate. However, despite
recent efforts to increase the participation of African Americans and Latinos in cancer clinical
trials (Alexander et al., 2000; G. Corbie-Smith et al., 2003; Ness et al., 1997; Tejeda et al.,
1996), their enrollment remains lower than that of non-Latino Whites (Murthy et al., 2004).
Reasons for lower rates of minority participation in clinical trials are multifaceted and
may be explained by past experiences of minority patients with medical research resulting in
negative attitudes toward clinical trials due to historical discrimination (Giselle Corbie-Smith et
al., 1999; Kaluzny et al., 1993; Snow, 1993). Limited health literacy and limited English
proficiency (LEP) are other key barriers to clinical trial recruitment (Joseph et al., 2009; Lloyd et
al., 2008), and minorities disproportionally have limited health literacy and are of LEP (National
Center for Education Statistics, 2006).
In addition, physician characteristics such as specialty and amount of time spent in
patient care impact clinical trial discussions, referral, and recruitment (Nguyen et al., 2005;
Siminoff et al., 2000). A review of the provider’s role in clinical trial participation suggests that
lack of physician awareness of clinical trials is a barrier to enrolling patients. Patient accrual is
also negatively affected by physicians’ attitudes towards patient adherence to the study protocol,
patient mistrust of research, and patient costs (Howerton et al., 2007). At the organizational
level, lower rates of clinical trial participation among minorities can be in part attributed to the
health care system failing to address these patients’ informational needs at appropriate language
and health literacy levels (Paasche-Orlow et al., 2007). This becomes especially apparent when
assessing communication capabilities of the clinical trial site, e.g. the healthcare organization’s
ability to provide linguistically appropriate and accessible information.
Given the number and complexity of available cancer clinical trials, it can be difficult for
patients, particularly minorities, those with limited health literacy and those of LEP, to determine
their potential eligibility which, by extension, limits their participation in trials. Patients often
struggle to understand and make decisions about research participation in the face of lifethreatening illness, multiple treatment options, and long-term physical, psychological, and
logistical concerns. In addition, not all facilities have bilingual personnel to assist with
recruitment and retention (Giuliano et al., 2000), which may particularly affect Latinos for whom
English is a second language (U.S. Department of Commerce Bureau of the Census, May 2001).
Thus, addressing the challenges of limited health literacy and LEP populations represents a
critical focus for advancing cancer trial participation among minorities and thus reducing health
disparities.
Recognizing this, the Institute of Medicine (IOM) has identified health literacy as an
urgent national priority area, emphasizing the critical role of the health care system in addressing
the needs of patients with limited health literacy (Brach et al., 2012). The IOM has defined
Journal of Health Disparities Research and Practice Volume 7, Issue 4
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“health literate organizations” as “institutions that support individuals in navigating the
complexities of the health care system” (Brach et al., 2012). The Health Literate Care Model is
based on the principles of “Health Literacy Universal Precaution” developed by AHRQ (DeWalt
et al., 2010). This model postulates the need for health care providers to approach all patients
with the assumption that health information may not be fully understood (DeWalt et al., 2010),
and incorporates recommendations to help health care systems reduce the complexity of medical
care and ensure that patients are able to succeed in the health care environment.
The Agency for Healthcare Research and Quality (AHRQ) developed a toolkit to assist
organizations in becoming health literate (DeWalt et al., 2010), recognizing that health literacyrelated outcomes are a function of both patient and health care system characteristics (PaascheOrlow et al., 2006; Paasche-Orlow et al., 2007). This toolkit provides a framework for
organizations to become more health literate (DeWalt et al., 2010), and suggests that language
competency (both written and verbal communication) and outreach efforts by organization (e.g.,
the clinical trials sites) are key to creating a health literate organization that addresses the needs
of minority and limited health literacy patients, particularly those with LEP. Little is known
about the organizational characteristics that are associated with language competency and
outreach efforts, and therefore likely to affect recruitment of minorities into clinical trials.
To extend the current state of knowledge in this area, our study explored the clinical trial
site (organizational) characteristics (e.g., practice type, racial/ethnic diversity of patient
population, language diversity of patient population and number of phase III trials offered) that
were associated with health literate behaviors (e.g., language competency and outreach) among
clinical trial sites in California, Florida, Illinois, and New York recruiting patients for breast
cancer trials in 2006.
METHODS
As part of a Department of Defense-funded project, we identified 384 breast cancer
clinical trials recruiting participants in 2006 from four states (California, Florida, Illinois, and
New York) through the Physician Data Query (PDQ) from the National Cancer Institute website.
These states were selected because of their large minority populations who were potentially
eligible to participate in clinical trials. We identified all sites implementing these trials (n=353)
and the research team members (RTMs) involved at each site. Trials were eligible for inclusion if
they were: a) located in California, Florida, Illinois, or New York; b) conducted in 2006; c)
related to breast cancer treatment; and d) funded by the National Institutes of Health (NIH)
and/or a pharmaceutical company. General information about the clinical trials, as well as
contact information for the sites where they were conducted was obtained from the PDQ. The
websites of the involved institutions were also consulted to obtain more detailed contact
information for the individuals involved in breast cancer clinical trials, hereafter referred to as
RTMs.
Research assistants contacted one RTM from each site to complete a brief phone survey
from October 2008 through November 2009. The survey was also available by mail, fax, or
email, depending on preference. Verbal informed consent was obtained prior to the survey. All
procedures were approved by the Committee on Human Research at the University of California
San Francisco.
Measures
Journal of Health Disparities Research and Practice Volume 7, Issue 4
2014

4 Health literate organizations: Are clinical trial sites equipped to recruit minority and limited health literacy patients?
Jennifer Livaudais-Toman et.al.

RTM characteristics
RTMs were asked to report their gender, country of birth, job title (clinical
manager/coordinator, nurse, director/investigator, data manager/administrative personnel), and
whether or not they spoke a language other than English.
Clinical trial site characteristics
RTMs were asked to describe their organization (e.g., practice type), and responses were
grouped as follows; a) solo or group practice, b) public community health center/public hospital,
c) VA, private or community based hospital, or d) University/medical school based
practice/research or cancer institute. RTMs were also asked to estimate the percentages of their
breast cancer patients who were Latina, Black or African American and had limited ability to
communicate in English (limited English proficiency – LEP). These percentages were assessed
continuously and dichotomized as ≥10% vs. <10%. For each site, we also obtained information
on the number of phase III trials currently being conducted (responses were dichotomized into
≥3 vs. <3).
Health literate characteristics
Communication (written and verbal), and outreach efforts were assessed to capture the
health literate characteristics of each trial site. We asked RTMs to report the availability, overall
and in languages other than English, of consent forms, summaries of studies, frequently asked
questions (FAQ) sheets about studies, directions to study site and appointment reminder cards.
We also asked about the availability of professional interpreter services and whether the sites
gave outreach presentations to community, social and service groups and churches and
participated in community health fairs or cancer awareness days to recruit patients.
Communication (written)
Consent documents. Respondents were asked whether printed consent documents were
available to patients in languages other than English (yes or no).
Supplementary information about clinical trials. Respondents were asked to indicate
whether their organizations provided summaries of clinical trials and frequently asked questions
(FAQ) sheets to patients overall (yes or no) and in a language other than English (yes or no). In
both instances, if a respondent answered yes to both questions (e.g., summaries and FAQ sheets),
their site was considered to offer supplementary information about clinical trials (overall or in
other languages)
Materials to facilitate recruitment into clinical trials. Respondents were asked to indicate
whether their organizations provided directions to the study site or appointment reminder cards
to patients overall (yes or no) and in a language other than English (yes or no). If a respondent
answered yes to either of these questions (e.g., directions or appointment reminder cards), their
site was considered to offer materials to improve patients’ navigation into clinical trials (overall
or in other languages).
Communication (verbal)
Professional interpretation services. Those sites offering professional onsite interpreters,
professional interpreter services by telephone, or professional video interpreter services were
considered to have professional interpretation services available.
Outreach
Outreach efforts. Respondents were asked about their sites’ general recruitment
strategies, including: presentations to community, social service groups, and churches and
Journal of Health Disparities Research and Practice Volume 7, Issue 4
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participation in community health fairs or cancer awareness days. If a respondent answered yes
to both of these recruitment strategies, their site was considered to engage in outreach efforts.
Analysis
Descriptive statistics were used to profile RTM characteristics, clinical trial site
characteristics and health literate characteristics of the sites. We explored associations between
individual clinical trial site characteristics (e.g., practice type, number of phase III trials, ≥10%
Latina patients, ≥10% African American patients and ≥10% LEP patients) and health literate
characteristics (e.g., communication and outreach). For each association, we used logistic
regression analysis to estimate odds ratios [OR] and 95% confidence intervals [CI] and
conducted all analyses in Stata Version 11.2. All comparisons were adjusted for state and
practice type (with the exception of the practice type analyses which were adjusted only for
state).
RESULTS
Sample characteristics. Of the initial 353 clinical trials sites selected, 85 were ineligible
(68 sites were excluded because they had the same staff and practices as another site that had
already completed the survey, 7 sites no longer conducted clinical trials, 1 was under new
management, 4 did not enroll breast cancer patients, and 5 never participated in clinical trials).
The remaining 268 were contacted for interviews. Twenty-two sites refused to participate, four
no longer employed RTMs and nine were never reached. This yielded 233 completed interviews
for a response rate of 87%.
Descriptive analysis
RTM characteristics. The majority of RTM respondents were female and born in the
United States (see Table 1). More than half of respondents identified themselves as the clinical
manager or clinical coordinator at their site, while 24% were nurses, 10% identified themselves
as the Director or a trial Investigator and 10% identified themselves as the data manager or
administrative personnel. Approximately one-quarter of respondents spoke another language in
addition to English.
Clinical trial site characteristics. Thirty-seven percent of trial sites were located in
California, 23% in New York, 20% in Illinois and 20% in Florida (see Table 1). The majority of
sites were solo or group practices, while more than one-quarter were public or community health
centers or hospitals, 20% were university or teaching hospitals or research/cancer institutes and
less than 10% were VA, private or community hospitals. On average, sites reported that 13% of
their breast cancer patients were African American, 15% were Latina, and 8% were LEP. Just
over half of the sites had 3 or more Phase III trials underway.
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Table 1. Research team member (RTM) and clinical trial site
characteristics (N=233)
n %a
RTM Characteristics
215 (92.7)
Female
201 (88.6)
Born in the U.S.
Job title
Clinical manager/coordinator
131 (56.5)
Nurse
55 (23.7)
Director/Investigator
22 (9.5)
Data manager/administrative personnel
24 (10.3)
60 (25.9)
Speaks another language
Clinical trial site characteristics
State
California
87 (37.3)
Illinois
47 (20.1)
New York
53 (22.8)
Florida
46 (19.7)
Type of Practice
Solo or group practice
105 (45.1)
Public community health center/hospital
63 (27.0)
VA, private or community hospital
21 (9.0)
University/teaching hosp/research or cancer institute
44 (18.9)
Patient population
% African American (mean ± SD)
12.5 ± 16.1
% Latinos (mean ± SD)
15.2 ± 18.2
% with limited English proficiency (mean ± SD)
8.4 ± 14.4
Number of Phase III Clinical trials
≤2
111 (47.6)
≥3
122 (52.4)
a
Percentages based on non-missing values

Health literate characteristics. Seventy-two percent of sites offered consent documents in
languages other than English (see Table 2). Slightly less than half of sites (48%) offered
supplemental information about clinical trials, including both summaries of studies and FAQ
sheets, and only 22% offered these materials in languages other than English. While the majority
of sites (80%) offered materials to facilitate recruitment into clinical trials (directions to study
site or appointment reminder cards), only 26% offered either of these materials in other
languages. Sixty-five percent of sites offered professional interpretation services. Less than half
of sites engaged in outreach efforts including both presentations to community, social and
service groups and churches and participation in community health fairs or cancer awareness
days.
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Table 2. Health Literate Characteristics of Clinical Trial Sites (N=233)

COMMMUNICATION (WRITTEN AND VERBAL)
Consent forms
Supplementary information about clinical trials (both types
available)
Summaries of studies
Frequently asked questions sheets about studies
Any materials to facilitate recruitment into clinical trials
Directions to study site
Appointment reminder cards
Professional interpretation services
OUTREACH
Outreach efforts (both types used)
Presentations to community, social and service groups, churches
Participation in community health fairs or cancer awareness days

Available for
Englishspeaking
patients
n (%)

Available for
non-Englishspeaking
patients
n (%)

23 (100)

167 (71.7)

112 (48.1)
153 (65.7)

52 (22.3)
78 (33.5)

144 (61.8)
186 (79.8)

79 (33.9)
61 (26.3)

105 (45.1)
161 (69.1)
n/a

39 (16.8)
41 (17.6)
151 (64.8)

105 (45.1)
117 (50.2)

n/a
n/a

160 (68.7)

n/a

Multivariable analyses
Health literate characteristics (overall) (Table 3)
Supplementary information about clinical trials. None of the clinical trial site
characteristics we explored were significantly associated with offering supplementary
information about clinical trials (summaries of studies and FAQs)
Materials to facilitate recruitment into clinical trials. Compared to solo or group practice
sites, sites within public or community health centers or hospitals (OR=0.28, 0.13-0.64), and
VA, private or community hospitals (OR=0.29, 0.09-0.94) were less likely to offer materials to
improve patient navigation to trials. Trial sites with patient populations of ≥10% LEP were also
less likely to offer these materials (OR=0.46, 0.21-0.99).
Outreach efforts. Compared to solo or group practice sites, university/teaching hospitals
and research/cancer institutes were more likely to engage in outreach efforts (OR=2.20. 1.034.70), as were sites with patient populations of ≥10% Latina compared to their counterparts
(OR=1.97, 1.07-3.60).
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Table 3. Adjusted Odds Ratios: Availability of services according to site characteristics (n=233)
COMMUNICATION
(Written)
Any materials to facilitate
recruitment into clinical
Supplementary information
trials
about clinical trials
OR (95% CI)
OR (95% CI)
Type of practicea
Solo or group practice
ref
Public community health
center/hospital
1.02 (0.54-1.92)
VA, private or community
hospital
0.60 (0.22-1.60)
University/teaching
hosp/research or cancer
institute
0.66 (0.31-1.40)
Number of phase III clinical trialsb
≤ 2 phase III trials
ref
≥3 phase III trials
1.55 (0.90-2.66)
Percent of Latinas in patient populationb
<10%
ref
≥10%
1.64 (0.91-2.96)
Percent of African Americans in patient populationb
<10%
ref
≥10%
1.10 (0.62-1.96)
Percent of patients who are LEPb
<10%
ref
≥10%
1.37 (0.72-2.62)
a

OUTREACH

Outreach efforts
OR (95% CI)

ref

ref

0.28 (0.13-0.64)²

1.80 (0.91-3.29)

0.29 (0.09-0.94)³

1.19 (0.44-3.22)

0.40 (0.15-1.07)

2.20 (1.03-4.70)³

ref
1.43 (0.73-2.83)

ref
1.07 (0.62-1.85)

ref
0.99 (0.47-2.07)

ref
1.97 (1.07-3.60)³

ref
1.33 (0.63-2.81)

ref
1.04 (0.58-1.86)

ref
0.46 (0.21-0.99)³

ref
1.42 (0.74-2.73)

Analyses adjusted for state

b

Analyses adjusted for state and practice type
¹p<0.05; ²p<0.01; ³p<0.05

Health literate characteristics (services available in other languages) (Table 4)
Consent forms in other languages. Trial sites with patient populations of ≥10% Latina
and ≥10% LEP were more likely than their counterparts to provide consent forms in other
languages (OR= 2.49, 1.28-4.85 and OR=3.13, 1.36-7.19 respectively).
Supplemental information about clinical trials in other languages. Trial sites with patient
populations of ≥10% Latina and ≥10% LEP were more likely than their counterparts to offer
supplemental information about clinical trials in other languages (OR=2.58, 1.24-5.36 and
OR=2.52, 1.15-5.52 respectively).
Materials to facilitate recruitment into clinical trials, in other languages. Trial sites with
patient populations of ≥10% Latina were more likely than their counterparts to offer materials in
other languages to improve access to care (OR=2.50, 1.22-5.13).
Professional interpretation services available. Compared to solo or group practice sites,
sites within public or community health centers or hospitals (OR=7.45, 3.32-16.8), VA, private
or community hospitals (OR=3.59, 1.20-10.7) and university/teaching hospitals and
research/cancer institutes (OR=4.22, 1.81-9.87) were more likely to provide professional
interpretation services.
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Table 4. Adjusted Odds Ratios: Availability of services in other languages, according to site characteristics
(n=233)
COMMUNICATION
(Written)

Consent forms in
other languages
OR (95% CI)
Type of practicea
Solo or group practice
ref
Public community
health center/hospital
0.76 (0.38-1.52)
VA, private or
community hospital
0.70 (0.25-1.90)
University/teaching
hosp/research or
cancer institute
1.11 (0.47-2.58)
Number of phase III clinical trialsb
≤ 2 phase III trials
(ref)
ref
≥3 phase III trials
0.70 (0.39-1.27)
Percent of Latinas in patient populationb
<10% (ref)
ref
≥10%
2.49 (1.28-4.85)²
Percent of patients who are LEPb
<10% (ref)
ref
≥10%
3.13 (1.36-7.19)²
a

(Written)
Supplementary
information about
clinical trials, in other
languages
OR (95% CI)

(Written)
Any materials to
facilitate recruitment
into clinical trials, in
other languages
OR (95% CI)

(Verbal)
Professional
interpretation
services
OR (95% CI)

ref

ref

ref

1.49 (0.70-3.18)

0.96 (0.46-2.03)

7.45 (3.32-16.8)¹

0.99 (0.25-3.94)

1.45 (0.49-4.31)

3.59 (1.20-10.7)³

1.35 (0.54-3.37)

1.14 (0.50-2.64)

4.22 (1.81-9.87)²

ref
1.05 (0.54-2.04)

ref
0.82 (0.45-1.51)

ref
1.79 (0.98-3.28)

ref
2.58 (1.24-5.36)³

ref
2.50 (1.22-5.13)³

ref
1.83 (0.93-3.62)

ref
2.52 (1.15-5.52)³

ref
2.02 (0.98-4.13)

ref
1.99 (0.92-4.30)

Analyses adjusted for state

b

Analyses adjusted for state and practice type
¹p<0.05; ²p<0.01; ³p<0.05

DISCUSSION
Patient and physician-level barriers to recruitment of minority patients into clinical trials
have been well described but less is known about the organizational characteristics that are
associated with language competency and outreach efforts, and therefore likely to affect
recruitment of minorities into clinical trials. Characteristics of the clinical trial environment can
influence whether or not minority, LEP, and limited health literacy patients participate in cancer
clinical trials (Brach et al., 2012). As recognized by the Agency for Healthcare Research and
Quality (AHRQ), language competency (written and verbal) and outreach efforts by clinical trial
sites are necessary components for creating health literate organizations that are equipped to
address the needs of minority and limited health literacy patients (DeWalt et al., 2010). The lack
of language competency and outreach to these patients on the part of cancer clinical trial sites
may explain in part the lower rates of trial participation documented in these groups (Alexander
et al., 2000; G. Corbie-Smith et al., 2003; Murthy et al., 2004; Ness et al., 1997; Tejeda et al.,
Journal of Health Disparities Research and Practice Volume 7, Issue 4
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1996). Overall, the clinical trial sites we examined made limited efforts to recruit ethnically and
linguistically diverse participants.
Information transfer within the informed consent process and full disclosure of
information regarding content and delivery of treatment in a clinical trial are believed to be
important predictors of recruitment of patients into trials (Wright et al., 2002). While the
majority of clinical trial sites offered consent forms to patients in languages other than English ,
consent forms are considered difficult to understand and interpret (Cornett, 2009; Davis et al.,
2002; Lorenzen et al., 2008) and may not sufficiently enable patients to make informed decisions
about participation. Offering materials that provide supplemental information about clinical trials
can be essential to encouraging participation. Short summaries of trials and FAQ sheets may
assist in making consent forms more comprehensible, allowing patients to make fully informed
decisions about participation (Institute, 2013). However, less than half of sites offered any
supplemental materials to patients, and even fewer offered these materials in languages other
than English. Of note, language competency, including the availability in other languages of
consent forms and supplementary information about clinical trials, was greatest among sites
serving diverse populations with large proportions of Latinos and LEP patients. The increased
availability of short summaries and FAQ documents in other languages at sites with more diverse
populations suggests that these sites are responding to the needs of their patient populations (e.g.,
Latinas and LEP patients) by providing materials in other languages.
While most sites offered materials including directions to the study site and appointment
reminders to facilitate patients’ navigation to clinical trials, hospitals were less likely to do so
than solo practices, as were sites with ≥10% LEP patients. In addition, very few sites offered
these materials in other languages. However, our results suggest that if these materials were
available at a site, those sites with more LEP patients were more likely to offer the materials in
other languages.
The use of professional interpretation services among LEP patients is associated with
improved quality of clinical care (Flores, 2005; Karliner et al., 2007), and is also likely to
facilitate recruitment of these patients into clinical trials. However, less than two-thirds of
clinical trial sites offered professional interpretation services. Solo and group practices were less
likely than other sites to do so. Resources available to larger institutions may partially explain the
discrepancy. With larger patient populations, the cost-effectiveness of interpretation services
may be greater due to economies of scale or shared resources across sites. In addition, the federal
government mandates health care providers who receive federal funding to provide language
interpretation services to their LEP patients (Blanchfield et al., 2011; Jacobs et al., 2006) and
larger institutions may be more likely to receive federal funding. Another potential explanation is
that solo and group practices had the least diverse patient populations in our study.
Outreach efforts are also a critical component of recruiting clinical trial participants,
particularly for difficult-to-reach populations including racial/ethnic minorities and those with
limited health literacy. Less than half of the clinical trial sites we studied engaged in community
outreach. University/teaching hospitals and research or cancer institutes were more likely than
solo or group practices to engage in outreach, as they may have been better equipped to do so,
given greater resources. Sites with more diverse patient populations were also more likely to
engage in outreach efforts. The latter finding provides further evidence that sites appear to be
responding to the needs of their patient populations by engaging in outreach efforts to target
difficult-to-reach individuals (e.g., Latinas).
Journal of Health Disparities Research and Practice Volume 7, Issue 4
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Several limitations to our study are worth noting. We were not able to interview RTMs
from all sites identified. If site characteristics differed between RTM respondents and nonrespondents, our findings may not be generalizable. Findings may also not be representative of
practices or behaviors in less diverse areas of the country since we selected trials conducted in
states with large minority populations. Language competency may be even poorer in less diverse
areas of the country. We did not assess the quality of materials translated into other languages or
their literacy level. Thus, the supplementary information provided about clinical trials may have
been written at a high literacy level. In addition, we relied on key informant RTMs from each
clinical trial site to answer questions about language competency and outreach. It is possible that
the person interviewed might not have had all of the necessary information to answer these
questions. However, we attempted to interview RTMs who were intimately involved in all
aspects of the clinical trials being conducted at their site.
Finally, data were cross sectional. As a result, we are unable to establish whether clinical
trial site characteristics influenced the patient population served, or whether trial sites adapted
their recruitment efforts to fit the needs of their specific patient population. Sites that do not
serve many LEP patients may have limited incentives or demand to provide patient materials and
study information in other languages. However, if these sites were to improve their language
competency, perhaps they would attract more culturally and linguistically diverse patients.

CONCLUSION
Language competency is an elemental characteristic of health literate organizations.
Without language appropriate materials or professional interpreter services, clinical trials sites
rely on ad hoc interpretation that may be imprecise and misleading. Improving cultural and
language competency is a desirable goal that can be strived for and potentially achieved by most
clinical trial sites. The failure to do so undermines the clinical trial site’s outreach and
recruitment efficacy and further undercuts national efforts to diversify the pool of clinical trial
participants (e.g. ENACCT, IMPACT, etc.). Our study identifies gaps in language competency
and outreach efforts at the organizational level, and therefore, gaps in responsiveness to the most
basic health literacy needs of patient populations at clinical trial sites across the United States.
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